Sandy Mahatme
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sandy Mahatme
Sandy Mahatme is recorded as CFO at Vor Biopharma Inc. (VOR). Vor Biopharma Inc. reported in an 8-K filed July 10, 2025 that Sandy Mahatme was appointed Chief Business Officer, effective July 9, 2025. Vor Biopharma Inc. reported in an 8-K filed July 10, 2025 that Sandy Mahatme was appointed Chief Financial Officer, effective July 9, 2025.
“Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Sandy Mahatme as Chief Financial Officer and Chief Business Officer, effective July 9, 2025.”
“Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Sandy Mahatme as Chief Financial Officer and Chief Business Officer, effective July 9, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-07-09–present
-
Vor Biopharma Inc. (VOR)
SEC 8-K
Current2025-07-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vor Biopharma Inc.
Other people whose current roles at this company are on record from its filings.
- Jean-Paul Kress CEO, Chairman, Board Member
- Jean-Paul Kress, M.D. CEO, Chairman, Board Member
- Han Choi, M.D., LL.M. CFO
- Robert Ang, M.B.B.S., M.B.A. CFO, Chief Accounting Officer
- Sandesh Mahatme CFO
- Amy Quinlan Chief Accounting Officer
- Alexander (Bo) Cumbo Board Member
- Andrew Levin Board Member
- David Zaccardelli, Pharm.D. Board Member
- Erez Kalir Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.